Evaluation of brain targeting in rats of Salvianolic acid B nasal delivery by the microdialysis technique. (3rd August 2018)

• Record Type: Journal Article
• Authors: Zhang, Suiling; Shi, Yajun; Tang, Lizhi; Wang, Jing; Guo, Dongyan; Wang, Mei; Zhang, Xiaofei
• Is Part Of: Xenobiotica. Volume 48:Number 8(2018:Aug.)
• Page Start: 851
• Page End: 859
• Publication Date: 2018-08-03
• Subjects: Brain microdialysis -- LC-MS -- nasal administration -- pharmacokinetics -- Salvianolic acid B; Metabolism -- Periodicals; Drugs -- Physiological effect -- Periodicals; Food additives -- Periodicals; Chemicals -- Physiological effect -- Periodicals; Biochemistry -- Periodicals; Pharmaceutical Preparations -- metabolism -- Periodicals; Metabolism -- Periodicals; 574.133
• DOI: 10.1080/00498254.2017.1373207
• Languages: English
• ISSNs: 0049-8254

Abstract

Abstract: The purpose of this study was to investigate the biodistribution of Salvianolic acid B in rats blood and brain after intranasal administration and explore its feasibility and evaluate its brain targeting effect. The concentration of Salvianolic acid B in blood and brain following nasal administration (32 mgċkg −1 ) was measured combining with microdialysis sampling and liquid chromatograph-mass spectrometer/MS detection technology. After the microdialysis samples were corrected with in vivo recoveries, the pharmacokinetic parameters were obtained by using non-compartment model and the brain targeting evaluated by the value of drug targeting index (DTI). The Cmax in blood and brain by intravenous injection were higher than intranasal administration, but the intranasal administration of MRT0-∞ significantly prolonged and increased by nearly 2.03 and 1.86 times, respectively. The DTI value of Salvianolic acid B was 5.54 and bioavailability (F) was 43.98%. After nasal administration of Salvianolic acid B, it has a certain brain targeting, which could become a new drug system for the treatment of brain diseases.